Veracyte Inc logo

VCYT - Veracyte Inc News Story

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647

BRIEF-Bayer And Veracyte Announce Precision Oncology Collaboration In Thyroid Cancer

Tue 22nd December, 2020 1:45pm
Dec 22 (Reuters) - Veracyte Inc  VCYT.O :
    * BAYER AND VERACYTE ANNOUNCE PRECISION ONCOLOGY
COLLABORATION IN
THYROID CANCER
    * VERACYTE INC - THROUGH PROGRAM, BAYER WILL OFFER TESTING
WITH
VERACYTE'S AFIRMA XPRESSION ATLAS (XA) TO IDENTIFY UNDERLYING
GENOMIC DRIVERS
    * VERACYTE INC - COMPANIES ANTICIPATE PROGRAM TO LAUNCH IN
Q1 OF
NEXT YEAR

Source text for Eikon:  ID:nBw9gsX1za 
Further company coverage:  VCYT.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.